Oncologist Ilir Kurtishi recently addressed the challenging realities of treating pancreatic cancer, emphasizing that surgical intervention is limited to a small subset of patients. During an appearance on the “Health First” podcast, supported by United Hospital, Kurtishi clarified that the diagnosis of pancreatic cancer is frequently made at advanced stages, which significantly impacts treatment options. He detailed that managing the disease requires a multidisciplinary approach, integrating chemotherapy, radiotherapy, and, where possible, surgery.
According to Kurtishi, the feasibility of surgery is highly dependent on the specific location and extent of the tumor. He explained that an operative procedure can only be performed if the disease is localized to a segment of the pancreas that allows for a viable surgical approach. “However, the number of patients who can be operated on is very small,” Kurtishi stated, underscoring the complexity of the condition.
The expert further elaborated that the majority of individuals diagnosed with pancreatic cancer present with advanced disease, making definitive surgical resection challenging for many. This underscores the critical need for early detection and comprehensive care planning. Kurtishi’s insights highlighted that while the goal of treatment is curative, the current medical landscape means that surgical options remain highly selective, requiring precise staging and careful assessment of the tumor’s relationship to surrounding vital structures.
This necessitates close collaboration among oncologists, surgeons, and radiation specialists to optimize care for every patient facing pancreatic cancer.
Topics: #kurtishi #pancreatic #cancer
